Based on the positive global Phase III MANEUVER study, the National Medical Products Administration (NMPA) has granted the ...
Becoming the second drug approved by the U.S. FDA for tenosynovial giant cell tumors, Deciphera Pharmaceuticals Inc.’s oral CSF1R inhibitor vimseltinib, newly branded Romvimza, could take significant ...
German pharma group Merck KGaA (MRK: DE) said China’s medicines regulator has approved pimicotinib for adults with ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window CHICAGO -- An ...
Abbisko Cayman Limited ( ($HK:2256) ) has issued an update. Abbisko Cayman Limited announced that its subsidiary Abbisko Therapeutics has received ...
The U.S. Food and Drug Administration (FDA) has approved vimseltinib (Romvimza TM) for adult patients with a rare condition called tenosynovial giant cell tumor (TGCT). TGCT is a tumor of the tissue ...
Tenosynovial giant cell tumors are not malignant but can impact patients’ quality of life, as one expert explained. There are not many patients with tenosynovial giant cell tumors, or TGCTs, with one ...
Becoming the second drug approved by the U.S. FDA for tenosynovial giant cell tumors, Deciphera Pharmaceuticals Inc.’s oral CSF1R inhibitor vimseltinib, newly branded Romvimza, could take significant ...
Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced today that following Priority Review, the ...
Pimicotinib is the first Class 1 chemical drug approved in China for the treatment of TGCT, with its approval based on results from the global Phase 3 MANEUVER study, in which the drug demonstrated ...
Systemic therapy and active surveillance can be viable options for patients with TGCT, as one expert explained. Sydney Stern has undergone six surgeries for TGCT, or tenosynovial giant cell tumors.
On August 8, 2025, the FDA granted accelerated approval to zongertinib for adult patients with unresectable or metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback